Safety and Efficacy of 630-nm Red Light on Cognitive Function in Older Adults With Mild to Moderate Alzheimer's Disease: Protocol for a Randomized Controlled Study

Frontiers in Aging Neuroscience
Nayan HuangZhiqian Tong

Abstract

Introduction: Studies have shown that excess formaldehyde accumulation in the brain accelerates cognitive decline in people with Alzheimer's disease (AD). Recently, reports from our research team revealed that red light treatment (RLT) improved memory in AD mice by activating formaldehyde dehydrogenase (FDH) and thus reducing formaldehyde levels. Here, we developed a medical RLT device to investigate the safety and efficacy of this device in older adults with mild to moderate AD. Methods: This will be a randomized controlled trial (RCT) that will include 60 participants who will be recruited and randomly divided into an RLT group and a control group. The RLT group will receive RLT intervention 5 days a week for 30 min each time for 24 weeks while the control group will continue their routine treatments without RLT. All participants will undergo neuropsychological and functional assessments including the Mini-Mental State Examination, the AD assessment scale-cognitive subscale (ADAS-cog), the Geriatric Depression Scale (GDS), the Neuropsychiatric Inventory (NPI) and the Barthel Index at baseline, 12 weeks and 24 weeks. All participants will undergo functional magnetic resonance imaging (fMRI) scanning and blood/urine biomarkers ...Continue Reading

References

Jan 1, 1982·Journal of Psychiatric Research·J A YesavageV O Leirer
Sep 10, 1999·BMJ : British Medical Journal·S Hollis, F Campbell
Jul 3, 2007·Photomedicine and Laser Surgery·U OronJ Streeter
Jul 20, 2011·International Journal of Geriatric Psychiatry·Tao WangYiru Fang
Jan 10, 2012·Cold Spring Harbor Perspectives in Medicine·Alberto Serrano-PozoBradley T Hyman
Aug 2, 2012·Journal of Alzheimer's Disease : JAD·Julio C RojasFrancisco Gonzalez-Lima
Sep 1, 2012·AJNR. American Journal of Neuroradiology·M H LeeJ S Shimony
Jan 11, 2013·BMJ : British Medical Journal·An-Wen ChanDavid Moher
Jun 27, 2013·Journal of Neurochemistry·Ketki Tulpule, Ralf Dringen
Feb 11, 2015·BMJ : British Medical Journal·Philip Sedgwick
Nov 2, 2016·Journal of Alzheimer's Disease : JAD·Zhiqian TongRongqiao He
Mar 30, 2017·The Neuroradiology Journal·K A SmithaChandrasekharan Kesavadas
Aug 16, 2017·Toxicology Mechanisms and Methods·Xudong LiuXu Yang
Sep 6, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C A LaneJ M Schott
Jan 13, 2018·Molecular Neurobiology·Farzad SalehpourMichael R Hamblin
Feb 13, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Jianping JiaSerge Gauthier
Apr 10, 2019·Chemical Research in Toxicology·Fei WangChunyuan Jin
Nov 14, 2019·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Xiangpei YueZhiqian Tong

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging technique
ELISA

Software Mentioned

Power Analysis and Sample Size
SPSS
Statistical Parametric Mapping
REST
SAS
MATLAB

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Related Papers

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
V NgA Fecteau
Surgery, Gynecology & Obstetrics
M KalayogluF O Belzer
© 2022 Meta ULC. All rights reserved